GSK2654911A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2654911A, covering 2018-06-18 to 2018-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age [Phase 1]